Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Persky Marla

Over the trailing 90 days, Persky Marla (Director at Xeris Biopharma Holdings, Inc.) traded $294K of stock (net buying $111K) in XERS, per 3 SEC Form 4 transactions.

Role
Director
Companies
XERS
Window
Trailing 90 days · 3 transactions · CIK 1270354
Net activity
+$111K ($203K bought · $91K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
XERSXeris Biopharma Holdings, Inc.3$203K$91K$111K

Transactions (3)

DateSymbolTypeSharesValueDescription
2026-06-04XERSBuy24.2K$0Grant, award or other acquisition
2026-06-04XERSBuy33.0K$203KGrant, award or other acquisition
2026-06-03XERSSell15.5K$91KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Persky's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free